Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial

Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Fertility and sterility 2017-06, Vol.107 (6), p.1329-1335.e2
Hauptverfasser: Nandi, Anupa, M.R.C.O.G, Bhide, Priya, M.R.C.O.G, Hooper, Richard, Ph.D, Gudi, Anil, M.R.C.O.G, Shah, Amit, M.R.C.O.G, Khan, Khalid, Ph.D, Homburg, Roy, F.R.C.O.G
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1335.e2
container_issue 6
container_start_page 1329
container_title Fertility and sterility
container_volume 107
creator Nandi, Anupa, M.R.C.O.G
Bhide, Priya, M.R.C.O.G
Hooper, Richard, Ph.D
Gudi, Anil, M.R.C.O.G
Shah, Amit, M.R.C.O.G
Khan, Khalid, Ph.D
Homburg, Roy, F.R.C.O.G
description Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.
doi_str_mv 10.1016/j.fertnstert.2017.03.028
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1899114604</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0015028217303035</els_id><sourcerecordid>1899114604</sourcerecordid><originalsourceid>FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</originalsourceid><addsrcrecordid>eNqNUsuO1DAQjBCIHRZ-AfnIJcGO4zw4IMGKx0orcQDOlmN32B4ce7CdhdmfgW_hy3CUASROyJJfVdXddnVREEYrRln7dF9NEJKLKc9VTVlXUV7Rur9T7JgQbSlawe8WO0qZKPN1fVY8iHFPKW1ZV98vzupeUMZbtiu-X7oU1JIDoQOCLsKMTiX0jnzFdE0-eaeMT8Ef0JGYcF7shvqQ2T9_3GDGyFoNWrzdoClj6RpICqDSDC4RP5HFwbeDVTmLIXEZT4p0fEYUCcoZP-NthrTP9Xhr8zYFVPZhcW9SNsKj03pefHz96sPF2_Lq3ZvLixdXpW66IZWj6Ouegh5o0zA2iG4EUJzTgQkwnItBG-jadtRqrCfVdxNvFeuHfDCNqcXEz4snW9xD8F8WiEnOGDVYqxz4JcpMHhhrWtpkar9RdfAxBpjkIeCswlEyKld75F7-tUeu9kjKZfYhSx-fsizjDOaP8LcfmfByI0B-6w1CkFEjOA0GA-gkjcf_yfL8nyDaokOt7Gc4Qtz7Jbj8l5LJWEsq369tsnYJ6zjNQ_BfTbzCZQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1899114604</pqid></control><display><type>article</type><title>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</title><source>MEDLINE</source><source>ScienceDirect Journals (5 years ago - present)</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Alma/SFX Local Collection</source><creator>Nandi, Anupa, M.R.C.O.G ; Bhide, Priya, M.R.C.O.G ; Hooper, Richard, Ph.D ; Gudi, Anil, M.R.C.O.G ; Shah, Amit, M.R.C.O.G ; Khan, Khalid, Ph.D ; Homburg, Roy, F.R.C.O.G</creator><creatorcontrib>Nandi, Anupa, M.R.C.O.G ; Bhide, Priya, M.R.C.O.G ; Hooper, Richard, Ph.D ; Gudi, Anil, M.R.C.O.G ; Shah, Amit, M.R.C.O.G ; Khan, Khalid, Ph.D ; Homburg, Roy, F.R.C.O.G</creatorcontrib><description>Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.</description><identifier>ISSN: 0015-0282</identifier><identifier>EISSN: 1556-5653</identifier><identifier>DOI: 10.1016/j.fertnstert.2017.03.028</identifier><identifier>PMID: 28501361</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Combined Modality Therapy - methods ; Combined Modality Therapy - utilization ; Comorbidity ; Female ; Fertilization in Vitro - utilization ; Gonadotropins - administration &amp; dosage ; Humans ; Infertility - diagnosis ; Infertility - therapy ; Insemination, Artificial - utilization ; Internal Medicine ; intrauterine insemination ; In vitro fertilization ; Male ; Obstetrics and Gynecology ; Ovarian Hyperstimulation Syndrome - epidemiology ; Ovarian Hyperstimulation Syndrome - prevention &amp; control ; Ovulation Induction - utilization ; Pregnancy ; Pregnancy Outcome - epidemiology ; Pregnancy Rate ; Risk Factors ; Treatment Outcome ; unexplained infertility ; unexplained subfertility ; United Kingdom - epidemiology</subject><ispartof>Fertility and sterility, 2017-06, Vol.107 (6), p.1329-1335.e2</ispartof><rights>2017</rights><rights>Crown Copyright © 2017. Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</citedby><cites>FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0015028217303035$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,776,780,3537,27901,27902,65306</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28501361$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Nandi, Anupa, M.R.C.O.G</creatorcontrib><creatorcontrib>Bhide, Priya, M.R.C.O.G</creatorcontrib><creatorcontrib>Hooper, Richard, Ph.D</creatorcontrib><creatorcontrib>Gudi, Anil, M.R.C.O.G</creatorcontrib><creatorcontrib>Shah, Amit, M.R.C.O.G</creatorcontrib><creatorcontrib>Khan, Khalid, Ph.D</creatorcontrib><creatorcontrib>Homburg, Roy, F.R.C.O.G</creatorcontrib><title>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</title><title>Fertility and sterility</title><addtitle>Fertil Steril</addtitle><description>Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.</description><subject>Adult</subject><subject>Combined Modality Therapy - methods</subject><subject>Combined Modality Therapy - utilization</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Fertilization in Vitro - utilization</subject><subject>Gonadotropins - administration &amp; dosage</subject><subject>Humans</subject><subject>Infertility - diagnosis</subject><subject>Infertility - therapy</subject><subject>Insemination, Artificial - utilization</subject><subject>Internal Medicine</subject><subject>intrauterine insemination</subject><subject>In vitro fertilization</subject><subject>Male</subject><subject>Obstetrics and Gynecology</subject><subject>Ovarian Hyperstimulation Syndrome - epidemiology</subject><subject>Ovarian Hyperstimulation Syndrome - prevention &amp; control</subject><subject>Ovulation Induction - utilization</subject><subject>Pregnancy</subject><subject>Pregnancy Outcome - epidemiology</subject><subject>Pregnancy Rate</subject><subject>Risk Factors</subject><subject>Treatment Outcome</subject><subject>unexplained infertility</subject><subject>unexplained subfertility</subject><subject>United Kingdom - epidemiology</subject><issn>0015-0282</issn><issn>1556-5653</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNUsuO1DAQjBCIHRZ-AfnIJcGO4zw4IMGKx0orcQDOlmN32B4ce7CdhdmfgW_hy3CUASROyJJfVdXddnVREEYrRln7dF9NEJKLKc9VTVlXUV7Rur9T7JgQbSlawe8WO0qZKPN1fVY8iHFPKW1ZV98vzupeUMZbtiu-X7oU1JIDoQOCLsKMTiX0jnzFdE0-eaeMT8Ef0JGYcF7shvqQ2T9_3GDGyFoNWrzdoClj6RpICqDSDC4RP5HFwbeDVTmLIXEZT4p0fEYUCcoZP-NthrTP9Xhr8zYFVPZhcW9SNsKj03pefHz96sPF2_Lq3ZvLixdXpW66IZWj6Ouegh5o0zA2iG4EUJzTgQkwnItBG-jadtRqrCfVdxNvFeuHfDCNqcXEz4snW9xD8F8WiEnOGDVYqxz4JcpMHhhrWtpkar9RdfAxBpjkIeCswlEyKld75F7-tUeu9kjKZfYhSx-fsizjDOaP8LcfmfByI0B-6w1CkFEjOA0GA-gkjcf_yfL8nyDaokOt7Gc4Qtz7Jbj8l5LJWEsq369tsnYJ6zjNQ_BfTbzCZQ</recordid><startdate>20170601</startdate><enddate>20170601</enddate><creator>Nandi, Anupa, M.R.C.O.G</creator><creator>Bhide, Priya, M.R.C.O.G</creator><creator>Hooper, Richard, Ph.D</creator><creator>Gudi, Anil, M.R.C.O.G</creator><creator>Shah, Amit, M.R.C.O.G</creator><creator>Khan, Khalid, Ph.D</creator><creator>Homburg, Roy, F.R.C.O.G</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170601</creationdate><title>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</title><author>Nandi, Anupa, M.R.C.O.G ; Bhide, Priya, M.R.C.O.G ; Hooper, Richard, Ph.D ; Gudi, Anil, M.R.C.O.G ; Shah, Amit, M.R.C.O.G ; Khan, Khalid, Ph.D ; Homburg, Roy, F.R.C.O.G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c479t-b58280ec904411957beea330915ed3359cde766bcab2fa87f36a189b2fd4d25f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Combined Modality Therapy - methods</topic><topic>Combined Modality Therapy - utilization</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Fertilization in Vitro - utilization</topic><topic>Gonadotropins - administration &amp; dosage</topic><topic>Humans</topic><topic>Infertility - diagnosis</topic><topic>Infertility - therapy</topic><topic>Insemination, Artificial - utilization</topic><topic>Internal Medicine</topic><topic>intrauterine insemination</topic><topic>In vitro fertilization</topic><topic>Male</topic><topic>Obstetrics and Gynecology</topic><topic>Ovarian Hyperstimulation Syndrome - epidemiology</topic><topic>Ovarian Hyperstimulation Syndrome - prevention &amp; control</topic><topic>Ovulation Induction - utilization</topic><topic>Pregnancy</topic><topic>Pregnancy Outcome - epidemiology</topic><topic>Pregnancy Rate</topic><topic>Risk Factors</topic><topic>Treatment Outcome</topic><topic>unexplained infertility</topic><topic>unexplained subfertility</topic><topic>United Kingdom - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Nandi, Anupa, M.R.C.O.G</creatorcontrib><creatorcontrib>Bhide, Priya, M.R.C.O.G</creatorcontrib><creatorcontrib>Hooper, Richard, Ph.D</creatorcontrib><creatorcontrib>Gudi, Anil, M.R.C.O.G</creatorcontrib><creatorcontrib>Shah, Amit, M.R.C.O.G</creatorcontrib><creatorcontrib>Khan, Khalid, Ph.D</creatorcontrib><creatorcontrib>Homburg, Roy, F.R.C.O.G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Fertility and sterility</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Nandi, Anupa, M.R.C.O.G</au><au>Bhide, Priya, M.R.C.O.G</au><au>Hooper, Richard, Ph.D</au><au>Gudi, Anil, M.R.C.O.G</au><au>Shah, Amit, M.R.C.O.G</au><au>Khan, Khalid, Ph.D</au><au>Homburg, Roy, F.R.C.O.G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial</atitle><jtitle>Fertility and sterility</jtitle><addtitle>Fertil Steril</addtitle><date>2017-06-01</date><risdate>2017</risdate><volume>107</volume><issue>6</issue><spage>1329</spage><epage>1335.e2</epage><pages>1329-1335.e2</pages><issn>0015-0282</issn><eissn>1556-5653</eissn><abstract>Objective To evaluate the best first line management option for the treatment of unexplained subfertility-controlled ovarian hyperstimulation (COH) with gonadotropins and IUI or IVF. Design Randomized controlled trial. Setting Single center trial in a tertiary referral unit. Patient(s) Couples with unexplained subfertility. Intervention(s) Couples were randomized to receive either three cycles of IUI + COH or one cycle of IVF. Main Outcome Measure(s) Singleton pregnancy rate (PR) per couple. Result(s) A total of 207 couples were randomly assigned to three cycles of IUI + COH (n = 101) or one cycle of IVF (n = 106). There were 25 (24.7%) singleton live births for the IUI + COH group and 33 (31.1%) for the IVF group (relative risk, 1.3; 95% confidence interval [CI] 0.81–1.96) with an absolute risk difference of 6.4% (95% CI −5.8% to 18.6%). The multiple pregnancies per live birth were 4 (13.8%) for the IUI + COH group and 3 (8.3%) for the IVF group (relative risk, 0.6; 95% CI 0.14–2.4). There were no cases of ovarian hyperstimulation syndrome (OHSS) in the IUI group and three cases of OHSS (3.7%) in the IVF group. There were 17 live births from spontaneous conception in between treatment cycles (8.2%). Conclusion(s) The singleton live birth rate with one cycle of IVF was not significantly different than three cycles of IUI + COH. Clinical Trial Registration Number ISRCTN43430382.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>28501361</pmid><doi>10.1016/j.fertnstert.2017.03.028</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0015-0282
ispartof Fertility and sterility, 2017-06, Vol.107 (6), p.1329-1335.e2
issn 0015-0282
1556-5653
language eng
recordid cdi_proquest_miscellaneous_1899114604
source MEDLINE; ScienceDirect Journals (5 years ago - present); Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Alma/SFX Local Collection
subjects Adult
Combined Modality Therapy - methods
Combined Modality Therapy - utilization
Comorbidity
Female
Fertilization in Vitro - utilization
Gonadotropins - administration & dosage
Humans
Infertility - diagnosis
Infertility - therapy
Insemination, Artificial - utilization
Internal Medicine
intrauterine insemination
In vitro fertilization
Male
Obstetrics and Gynecology
Ovarian Hyperstimulation Syndrome - epidemiology
Ovarian Hyperstimulation Syndrome - prevention & control
Ovulation Induction - utilization
Pregnancy
Pregnancy Outcome - epidemiology
Pregnancy Rate
Risk Factors
Treatment Outcome
unexplained infertility
unexplained subfertility
United Kingdom - epidemiology
title Intrauterine insemination with gonadotropin stimulation or in vitro fertilization for the treatment of unexplained subfertility: a randomized controlled trial
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T21%3A36%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intrauterine%20insemination%20with%20gonadotropin%20stimulation%20or%20in%C2%A0vitro%20fertilization%20for%20the%20treatment%20of%20unexplained%20subfertility:%20a%20randomized%20controlled%20trial&rft.jtitle=Fertility%20and%20sterility&rft.au=Nandi,%20Anupa,%20M.R.C.O.G&rft.date=2017-06-01&rft.volume=107&rft.issue=6&rft.spage=1329&rft.epage=1335.e2&rft.pages=1329-1335.e2&rft.issn=0015-0282&rft.eissn=1556-5653&rft_id=info:doi/10.1016/j.fertnstert.2017.03.028&rft_dat=%3Cproquest_cross%3E1899114604%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1899114604&rft_id=info:pmid/28501361&rft_els_id=S0015028217303035&rfr_iscdi=true